Pershing Square Announces New Position in Valeant Pharmaceuticals International
Amsterdam, 9 Mar. 2015 //- Pershing Square Holdings, Ltd. (ticker: PSH:NA) announced today
a new position in Valeant Pharmaceuticals International, Inc. (ticker: NYSE: VRX) representing
approximately 16.9% of the PSH portfolio (based on the closing NAV of PSH and the closing
share price of VRX on Friday, 6 March 2015).
Pershing Square Capital Management, L.P., the investment manager for Pershing Square
Holdings, Ltd., announced that various funds it manages have purchased 16,473,933 shares of
Valeant Pharmaceuticals International, Inc., representing 4.9% of Valeant.